ArticleFrontiers in public health2025
Outbreak of Crimean-Congo hemorrhagic fever in Kyzylorda region, Kazakhstan, March-July 2022.
Article in Frontiers in public health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Integrated surveillance, virus isolation and phylogenetic characterization of Crimean-Congo hemorrhagic fever virus in Central Kazakhstan.Frontiers in veterinary science · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Crimean-Congo hemorrhagic fever (CCHF) is a tick-borne zoonotic disease characterized by a high case fatality rate of ~30%. CCHF is endemic in Kyzylorda Oblast, Kazakhstan, which has a population of 800,000, with approximately 10 cases reported annually. In 2022, by end of July, 15 cases had been reported. We conducted an investigation to identify the risk factors associated with CCHF and to recommend preventive measures. Methods: We conducted a case-control study. Case-patients were defined as individuals hospitalized between April and July 2022, showing signs consistent with CCHF and having a history of exposure-contact with ticks or animals and sudden onset of unexplained bleeding-within 2 weeks before the onset of illness. Confirmed case-patients additionally tested positive for CCHF-using both polymerase chain reaction (PCR) and enzyme-linked immunosorbent assay (ELISA) for both immunoglobulin M (IgM) and immunoglobulin G (IgG) tests. For every case-patient, two people from neighboring households were selected as controls. We used logistic regression to assess the factors associated with CCHF. Ticks collected from animals residing on the case-patient's property were tested for CCHF. We also reviewed public environmental and livestock data. Results: We studied 17 suspected, 7 probable, and 14 confirmed case-patients, along with 71 controls. Case-patients were predominantly male (74%), 47% were livestock workers and 37% were agricultural workers. Among the 14 confirmed CCHF case patients, 4 died from the illness (case fatality rate: 29%). Among the all case-patients, 100% reported weakness, 97% headaches, and 84% fevers. Over half (53%) of case-patients reported ticks on their bodies and clothing ≤2 weeks before the onset of the illness compared to 1% of controls ( Conclusion: We found a high occupational risk for CCHF. The prevalence of CCHF in ticks in our study was 0.6%, which is consistent with regional tick surveillance data. Increased tick control measures and personal protective measures for people with occupational exposure to ticks may help reduce cases.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.